18 related articles for article (PubMed ID: 18544021)
1. Passively Acquired Constant Region 5-Specific Antibodies Associated With Improved Survival in Infants Who Acquire Human Immunodeficiency Virus.
Yaffe ZA; Sung K; Bosire R; Farquhar C; Ngacha DM; Lohman-Payne B; Nduati R; John-Stewart G; Matsen FA; Overbaugh J
Open Forum Infect Dis; 2023 Jul; 10(7):ofad316. PubMed ID: 37426948
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic HIV Env C5/gp41 vaccine candidate Vacc-C5 induces specific T cell regulation in a phase I/II clinical study.
Brekke K; Sommerfelt M; Ökvist M; Dyrhol-Riise AM; Kvale D
BMC Infect Dis; 2017 Mar; 17(1):228. PubMed ID: 28340570
[TBL] [Abstract][Full Text] [Related]
3. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.
Liang Y; Guttman M; Williams JA; Verkerke H; Alvarado D; Hu SL; Lee KK
J Virol; 2016 Oct; 90(20):9224-36. PubMed ID: 27489265
[TBL] [Abstract][Full Text] [Related]
4. Special anniversary review: twenty-five years of human immunodeficiency virus research: successes and challenges.
Weiss RA
Clin Exp Immunol; 2008 May; 152(2):201-10. PubMed ID: 18373700
[TBL] [Abstract][Full Text] [Related]
5. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
[TBL] [Abstract][Full Text] [Related]
6. HIV gp120 plus specific peptides are recognized in a similar manner to specific HLA plus peptide by HLA-restricted antigen-specific T-cell lines.
Sheikh J; Souberbielle B; Westby M; Austen B; Dalgleish AG
Viral Immunol; 2000; 13(1):9-17. PubMed ID: 10733164
[TBL] [Abstract][Full Text] [Related]
7. Human immunodeficiency virus type 1 gp120 C5 region mimics the HLA class I alpha 1 peptide-binding domain.
Lopalco L; De Santis C; Meneveri R; Longhi R; Ginelli E; Grassi F; Siccardi AG; Beretta A
Eur J Immunol; 1993 Aug; 23(8):2016-21. PubMed ID: 8344367
[TBL] [Abstract][Full Text] [Related]
8. Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
Prabakaran P; Gan J; Wu YQ; Zhang MY; Dimitrov DS; Ji X
J Mol Biol; 2006 Mar; 357(1):82-99. PubMed ID: 16426633
[TBL] [Abstract][Full Text] [Related]
9. Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.
Nanjundappa RH; Wang R; Xie Y; Umeshappa CS; Xiang J
Vaccine; 2012 May; 30(24):3519-25. PubMed ID: 22484292
[TBL] [Abstract][Full Text] [Related]
10. HLA homology within the C5 domain promotes peptide binding by HIV type 1 gp120.
Cadogan M; Austen B; Heeney JL; Dalgleish AG
AIDS Res Hum Retroviruses; 2008 Jun; 24(6):845-55. PubMed ID: 18544021
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
